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EDITORIAL REVIEW
Dialysis disequilibrium syndrome: Current concepts on
pathogenesis and prevention
Dialysis disequilibrium syndrome is a clinical disorder which
occurs in patients with end-stage renal disease who are being
treated with hemodialysis. The syndrome has been described
since about 1962 [1, 2] and symptoms may include headache,
nausea, emesis, blurring of vision, muscular twitching, disori-
entation, hypertension, tremors and seizures [3]. Additional
symptoms more recently described include muscle cramps,
anorexia, restlessness, and dizziness [4]. Although dialysis
disequilibrium syndrome has been reported among all age
groups, it is more common among younger patients, particu-
larly the pediatric age group [5]. The electroencephalogram
(EEG) after hemodialysis was originally reported as abnormal
on the basis of simple visual analysis [1, 6] but this has not been
confirmed when the EEG was subjected to the more precise
frequency and power spectra analysis [7, 8].
Dialysis disequilibrium syndrome is one of several central
nervous system abnormalities which may occur in patients with
chronic renal failure. Several of these disorders appear to
develop as a consequence of dialytic therapy, and include
dialysis dementia [3] and progressive intellectual impairment
[9], as well as dialysis disequilibrium syndrome [1, 10]. The
syndrome is most often associated with rapid hemodialysis of
patients who have just started hemodialysis, although it may
also occur, but far less frequently, following maintenance
hemodialysis of patients with chronic renal failure [3, 11]. The
incidence is very high among patients with pre-existing neuro-
logical disease, such as head trauma, recent stroke or malignant
hypertension [12]. There has been much debate about the
pathogenesis of dialysis disequilibrium syndrome [4, 11, 13—15]
and the issue remains in part unresolved.
Symptoms of dialysis disequilibrium syndrome
Mild forms of dialysis disequilibrium may be manifested by
no more than restlessness and severe headache, which may
occur during or soon after hemodialysis. This is commonly
followed by nausea and vomiting, often accompanied by blood
pressure elevation. These symptoms may be accompanied by
disorientation and tremors. Seizures and cardiac arrhythmias
have been reported in the older literature but are uncommon
today. The symptoms are usually self limited but recovery may
take several days. In some instances the seizures may lead to
coma. The symptoms of dialysis disequilibrium syndrome re-
ported since about 1970 have generally been milder, consisting
of nausea, weakness, headache, fatigue, and muscle cramps.
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This is probably due to the greatly improved management of
patients with renal failure undergoing hemodialysis in more
recent years. It is unclear whether any patient ever actually
died from dialysis disequilibrium syndrome or rather from other
associated neurological complications, such as acute stroke,
subdural hematoma, subarachnoid hemorrhage, head trauma or
malignant hypertension [3, 12]. Recently, the diagnosis of
dialysis disequilibrium syndrome has become a "wastebasket"
for a number of disorders which can occur in patients with renal
failure and may affect the central nervous system. It should be
stressed that the diagnosis of dialysis disequilibrium syndrome
should be one of exclusion [16].
Pathogenesis of dialysis disequilibrium syndrome
Early clinical investigation in patients with dialysis disequi-
librium syndrome included evaluation of cerebrospinal fluid
(CSF) pressure and composition of the CSF. In patients with
dialysis disequilibrium syndrome, findings included a persistent
elevation of CSF pressure, and levels of urea which were higher
in CSF than in blood [2]. These findings led to early speculation
that cerebral edema was responsible for most of the manifesta-
tions of dialysis disequilibrium syndrome. It is now clear that
many of the clinical manifestations of dialysis disequilibrium
syndrome are in fact largely due to brain swelling which occurs
as a consequence of the dialysis procedure. This has been well
documented in studies of uremic laboratory animals which have
undergone hemodialysis. Such a procedure has resulted in brain
edema in several different studies [14, 17], although most of the
brain swelling is confined to cortical gray matter. A recent study
in the rat was based primarily on examination of cerebral white
matter, but even here some brain edema was present [18].
Brain edema has been confirmed both at autopsy and by CT
scanning in humans with renal failure who have undergone
dialysis [12, 19]. However, stable patients with chronic renal
failure who undergo repeated hemodialysis may not develop
brain swelling (based on CT of the brain), and this probably
relates to the general absence of dialysis disequilibrium syn-
drome in such patients [8]. An animal model of dialysis disequi-
librium syndrome was developed in the uremic dog [17]. When
uremic dogs (plasma urea about 70 mmollliter) were hemodia-
lyzed for 100 minutes at a high blood flow rate, lowering the
plasma urea from about 70 to 25 mmollliter, a situation devel-
oped where the animals manifested tremors and grand mal
seizure activity. The plasma osmolality in these animals was
lowered by about 40 mOsmlkg H20 (from 345 to 306 mOsmlkg
H20) over 100 minutes (0.40 mOsm/kg H20/min), and this
model was felt to be a valid model of dialysis disequilibrium
syndrome. When dogs with the same degree of uremia were
dialyzed with lower blood and dialysate flow rates, with a
similar decrement of plasma urea over 200 minutes rather than
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100 minutes, symptoms of dialysis disequilibrium were absent
and brain edema was much less [17].
In a recent study [18] the animals (rats) were anesthetized and
treated with hemodialysis. As they were under anesthesia, it is
unclear if they would have developed seizures or other neuro-
logic manifestations of disequilibrium. Following 90 minutes of
dialysis in these uremic rats, the fall in plasma osmolality was
16 mOsm/kg (350 to 334 mOsmlkg H20, or 0.18 mOsmlkg
H20/min). A 2.6 fold greater decline of plasma osmolality (42
mOsm/kg) after hemodialysis of uremic dogs had been noted to
cause no biochemical disequilibrium [17] if the rate of decline in
plasma osmolality was similar (0.20 mOsm/kg H20/min). There-
fore, data obtained from this model must be interpreted with
caution, since it is unclear whether neurological manifestations
would have developed, and the model lacks certain features
previously demonstrated [14, 17] to be associated with dialysis
disequilibrium syndrome.
"Reverse urea" effect
The presence of brain edema in some patients with dialysis
disequilibrium syndrome, along with the observation that in
patients undergoing rapid hemodialysis, urea levels are higher
in CSF than in blood, led to formulation of the "reverse urea"
hypothesis. In general, the "reverse urea" effect assumes that
concentrations of urea are similar in plasma, CSF and brain
tissue water. With rapid hemodialysis, it was assumed, without
documentation, that clearance of urea would be more rapid
from plasma than from brain tissue. Such an assumption
stemmed from the observed slower clearance of urea from CSF
than from plasma [2, 10] in patients undergoing rapid hemodi-
alysis. The decrement of plasma urea leads to a fall in plasma
osmolality. It was postulated that, with a slower clearance of
urea from brain, osmolality of brain tissue remained elevated
above that of plasma, leading to a net movement of water from
plasma into brain with resultant cerebral edema [10]. However,
the "reverse urea" hypothesis has not been supported by
experimental investigation. In both uremic patients and labora-
tory animals (dogs) subjected to rapid hemodialysis, urea levels
in CSF are consistently higher than those of plasma. However,
actual analysis of brain tissue (cerebral cortex) from uremic
animals, and from uremic animals treated with hemodialysis,
has not revealed a significant difference between urea concen-
trations in plasma versus brain water [14, 17, 20]. Recent data
[181 suggested that in undialyzed uremic animals, brain urea
was about 20 mmollliter less than that in plasma (53 mmol/kg vs.
72 mmol/kg). This result was different both from previous work
and also from a subsequent study in the uremic rat [21], where
both the urea and osmolality in plasma and brain were found to
be similar. As originally described [2], urea levels after hemo-
dialysis are higher in CSF than plasma [17]. The elevated urea
levels in CSF do not reflect brain tissue levels, and are probably
a function both of the small surface area available for exchange
of CSF with blood, and the "sink" action of the CSF [221, a
mechanism which is intact in uremia [23].
Plasma to brain urea equilibrium
The "reverse urea" hypothesis not only has not been con-
firmed by experimental evidence, but on physiological grounds,
such a phenomenon would appear to be highly improbable.
Studies from at least six different laboratories have evaluated
the relationship between brain urea and plasma urea in a steady
state (more than about 6 hr) in at least four different species
(cat, rat, dog, rabbit). All find that brain and plasma urea
concentrations are virtually identical [14, 17, 21, 24—26] (Fig. 1).
Thus, the equilibrium distribution ratio for brain versus plasma
urea has been found by essentially all investigators to be about
one (Fig. 1). In cerebral membrane vesicles, it was found that
there was essentially no impediment to movement of urea from
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Fig. 1. The relationship between
simultaneous urea concentrations in brain ()
versus plasma (U) under steady state
conditions. The names on the bottom refer to
the first authors of the citations and the year
published. It is clear, with only a single
exception [181, that over a range of plasma
urea of 18 to 162 mmol/kg H20, brain and
plasma urea concentrations are virtually
identical. The data are extracted from [14, 17,
18, 24—26].1992
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brain to extracellular fluid in both normal and uremic rats [27].
At one time, intravenous hypertonic urea was often used to
reduce intracranial pressure by creating an osmotic gradient
between brain and plasma [28]. However, this resulted in a
biexponential curve of CSF pressure reduction after intrave-
nous urea [28], undoubtably because of gradual diffusion of urea
into the brain. Mannitol reduces intracranial pressure in a
monoexponential manner, and largely for this reason has be-
come the most widely used osmotic agent for decreasing
intracranial pressure [29], including patients with dialysis dis-
equilibrium [4].
Effects of dialysis on urea equilibrium between plasma and
brain
The ratio of urea in plasma versus brain (plasma urea/brain
urea) is essentially one (in a steady state) [14, 17, 21, 24—26] and
there is no barrier to removal of urea from the cerebral cortex
(gray matter) of the brain [27]. Thus, when plasma urea is
lowered, urea should leave the cerebral cortex at a similar rate.
Although limited data are available, this has generally been
observed, where after rapid lowering of plasma urea, cerebral
cortex urea differs from plasma by only about 7 mmol/kg H20
[17]. In brain white matter, because of a lesser blood flow, urea
efflux is somewhat delayed when compared to gray matter [17].
Data were recently presented [18] suggesting that in a rat model
of uremia, treatment with dialysis lowered brain urea by only 8
mmol/kg H20 (from 53 to 45 mmollkg H20), despite the fact
that the plasma urea fell from 72 to 34 mmollliter (—38 mmoll
liter). It should be considered that these data may in fact be
artifactual, based on several physiological inconsistencies. Dur-
ing slow dialysis, the brain osmolality is reported to have fallen
from 390 to 334 (a decline of 56 mOsm/kg H20) over 90 minutes,
during which time the urea fell by only 8 mOsm/kg H20 and the
sodium and potassium did not change at all. Thus, in the
absence of any change in major brain osmotic constituents
except urea (by 8 mmol/kg H20), the brain osmolality is
reported to have fallen by over 50 mmol/kg H20. Such data
appear to be physiologically inconsistent, and it is possible that
there may have been methodological errors in the measurement
of brain urea and/or osmolality [18].
Brain and plasma osmotic equilibrium
As is the case with elevated blood urea, concomitant brain,
CSF and plasma osmolalities have been compared in a number
of different steady state conditions, both normal and patholog-
ical. Brain tissue osmolalities have been measured by a number
of different technologies, including extraction in boiling distilled
water, vapor pressure osmometry, freezing point depression of
liquid nitrogen-frozen tissue, and freezing point depression of
liquid nitrogen-frozen, homogenized, centrifuged tissue [30—
34]. There are assorted technical problems with all of these
methodologies, in particular, the activity coefficient of the brain
intracellular solutes in vitro versus in vivo, bound water, and
breakdown of large organic molecules to smaller ones. Some of
these problems have recently been discussed [351. Even allow-
ing for the aforementioned methologic errors, in general, the
osmolalities of brain and CSF have been found to be essentially
equal, while plasma and brain differ by about 5 mOsm/kg H20,
which is about the normal difference between plasma and CSF
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Fig. 2. The relationship between osmolality of brain tissue versus that
of cerebrospinal fluid (CSF) in six groups of rabbits who had been
maintained in a steady state for at least two hours. The groups are:
closed circle, normal; closed triangle, alloxan diabetes (10 to 16 days);
open triangle, glucose infusion (2 to 6 hr); open circle, hypoxia (2 hr);
closed circle, hypoglycemia (146 to 208 mm); and open square, water
intoxication (2 hr). The ratios of (brain osmolality/CSF osmolality)
ranged from 0.92 to 1.07. y = 0.86x + 45; N = 70; r = 0.86; P < 0.001.
Used with permission from ARIEFF A!, DOERNER T, ZELIG H, MASSRY
SO: Mechanisms of seizures and coma in hypoglycemia. Evidence for
a direct effect of insulin on electrolyte transport in brain. J Gun Invest
54:654—663, 1974
osmolality [36]. These findings have been confirmed employing
several different methodologies in at least six different animal
species (cat, rat, dog, rabbit, guinea pig) [21, 30, 31, 33, 34,
37—41]. In general, osmolalities of brain and CSF have consis-
tently been found to be essentially equal under steady condi-
tions [34]. Brain osmolality has been measured in a wide variety
of pathological conditions (Fig. 2) covering a range of plasma
osmolalities of 250 to 380 mOsm/kg H20, and the osmolalities of
plasma, CSF and brain are consistently very similar [34, 40]. In
a recent study, it was reported that in control animals, brain
osmolality was 27 mOsmtkg greater than that of plasma (317 vs.
290 mOsmlkg H20) [18] in a steady state, this being somewhat
at variance with other work in this area. A similar relationship
was reported in measurements of brain osmolality in uremic
animals [18], where uremic brain osmolality was 29 mOsmlkg
H20 greater than the corresponding plasma osmolality (390 vs.
361 mOsm/kg H20) in a steady state of renal failure. If such a
relationship were actually present, the osmotic gradient should
lead to brain edema in both control and uremic animals [34, 42,
43]. However, brain edema has never been observed in uremic
animals [14, 17, 44] or humans [8, 19, 45, 46], leading to some
physiological inconsistency [18]. Additionally, after hemodial-
ysis of the uremic rats, plasma osmolality fell by only 16
mOsm/kg H20, while that in brain fell by over SO mOsmlkg
H20. The occurrence of such a phenomenon is difficult to
explain, based on fundamental concepts governing osmotic
equilibrium in brain [21, 30, 47—49].
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The reported physiological circumstances [18] would require
that there be edematous brain in both normal and uremic
animals, conditions which have not been found to be present
[14, 17, 45, 46]. It appears likely that at least some of the
methodology employed in this study [181 might have been at
fault, and possible sources of error may be contained within the
measurements of brain osmolality. Brain tissue was obtained by
decapitation, with subsequent removal of the brain. During
such a period of time, it has been demonstrated that significant
tissue breakdown occurs, with a false elevation of brain osmo-
lality [39]. Additionally, the samples were weighed before
addition of boiled water, allowing for additional tissue break-
down. Tissue samples from rat brain would of necessity be
much smaller than those originally utilized [34], resulting in a
large "dilution factor," which, when coupled with the error of
most commercial osmometers (2 mOsm/kg H20), means that a
measurement error of only 2 mOsmlkg H20 could result in an
error in tissue osmolality of up to 40 mOsmlkg H20.
Overall, it is clear from the study of Silver et a! [18] that after
a "slow" hemodialysis (90 mm, with a fall in plasma osmolality
of 0.20 mOsmlkg H20/min), no disequilibrium is present and the
difference between and plasma osmolality is about 10 mmol/kg
H20, almost identical to that which had previously been re-
ported [17].
Role of brain intracellular pH in the pathogenesis of dialysis
disequilibrium syndrome
To understand how changes of brain intracellular pH (pH1)
could play a role in the pathogenesis of dialysis disequilibrium
syndrome, it is first necessary to briefly review certain aspects
of brain acid-base regulation. Intracellular acid-base status has
been extensively evaluated in both uremic humans and various
animal models of acute or chronic renal failure. In earlier
studies, the brain was usually evaluated by measuring the
distribution of radioactive (4C) dimethadione (DM0) [50]. This
technique is invasive, requiring the measurement of DM0 in
brain tissue biopsies, and is thus unsuitable for repeated mea-
surements of brain pH1 in the same animal [51]. Brain pH1 can
also be determined by measuring the distribution of CO2 in
brain, the technique being similar to the DM0 method [52].
Currently, the "gold standard" for measurement of brain pH1 is
by magnetic resonance spectroscopy (MRS), a noninvasive
technique suitable for repeated measurements in the same
animal [53, 54]. Although there are certain theoretical problems
with the DM0 method [55], the values for brain pH, are very
similar to those obtained using MRS [56]. In animals who have
acute renal failure and metabolic acidosis, the pH1 in brain and
skeletal muscle is normal [57—59]. In patients with chronic renal
failure, pH1 has been reported to be normal in skeletal muscle,
leukocytes [60, 61], and the "whole body" [62]. In dogs with
chronic renal failure, despite a metabolic acidosis, the pH, is
normal in several different parts of the brain, as well as liver and
skeletal muscle [44] (Fig. 3). The pH, of brain has not yet been
evaluated in uremic humans, although newer techniques, such
as magnetic resonance spectroscopy, now permit such param-
eters to be measured in vivo [63, 641. The pH of CSF has also
been shown to be normal in both patients and laboratory
animals with renal failure [6, 15, 58, 65]. Thus, in uremic
animals and humans, despite the presence of extracellular
Fig. 3. The intracellular pH (pH1) of brain (cerebral cortex) and
skeletal muscle in uremic dogs (•), and dogs treated with either rapid
(El) or slow (111111) hemodialysis (HD). After slow HD, there is a small but
not significant fall in brain pH,. After rapid HD, there is a highly
significant fall in brain pH1; the pH1 of muscle is unaffected by either
uremia or HD. Used with permission from ARIEFF Al, GulsADo R,
MASSRY SO, LAZAROWITZ VC: Central nervous system pH in uremia
and the effects of hemodialysis. J Clin Invest 58:306—311, 1976
metabolic acidosis, the intracellular buffering capacity of brain,
muscle and other tissues is capable of maintaining pH1 in the
normal range.
There is evidence for a paradoxical acidemia of CSF in both
patients and laboratory animals treated with rapid hemodialy-
sis. In patients treated with rapid hemodialysis, there is often a
fall in pH of the CSF despite a rise in arterial pH [15, 65] (Fig.
4). A similar fall in pH of CSF occurs after rapid hemodialysis
of experimental animals with renal failure [58]. The fall in pH of
CSF probably indicates a concomitant decrement of cerebral
pH,, based on studies in the uremic dog (Fig. 3) [51]. There is a
postulated mechanism whereby correction of arterial pH can
lead to a paradoxical decline in pH of the CSF [66] with pH
normal in blood, but low in the CSF. Such a sequence may
occur after correction of arterial pH in patients with cholera or
diabetic ketoacidosis [67, 68], but is not usually of clinical
significance. However, available evidence, both in patients with
chronic renal failure and uremic dogs, strongly suggests that
such a sequence of events does not occur either after or during
hemodialysis. Furthermore, in animals with acute renal failure
treated with rapid hemodialysis, dialysis disequilibrium occurs
in the absence of any change in arterial pCO2 [17]. Also, in
patients treated with rapid hemodialysis, no difference in the
pCO2 or bicarbonate of either plasma or lumbar CSF was found
whether dialysis disequilibrium was present or not [6, 15, 65,
69]. However, most of the decrement in pH of CSF observed
during rapid hemodialysis is not due to an increase of pCO2 in
CSF but rather to a fall in CSF bicarbonate concentration [58].
The fall in CSF bicarbonate is not due to an increment of lactate
in CSF, but rather appears to be due to the presence of organic
acid anions whose identity has not yet been determined.
Along with the decrement in pH of CSF, there is an observed
decrease in the pH, of brain (Fig. 3). In dogs with acute renal
failure (ARF), pH1 is normal in brain and skeletal muscle [58,
59]. After rapid hemodialysis, there is no change in the pH1 of
muscle, but a significant decrement is observed in the pH1 of
both CSF [17] and cerebral cortical gray matter [58] (Figs. 3 and
Arieff: Dialysis disequilibrium 633
I
0
C)0
C)
CD
0
0
CD
Fig. 4. Changes in arterial blood and cerebrospinal fluid (CSF) during
rapid hemodialysis (HD). During HD, the blood pH increases from 7.22
0.02 to 7.31 0.01, while bicarbonate rises from 13.7 1.0 to 17.7
0.7 mmol/liter. The simultaneously determined pH in CSF falls from
7.33 0.02 to 7.19 0.02, while CSF bicarbonate falls from 18,9 1.1
to 15.4 0.5, mmol/liter. There was no change in arterial blood PCO2.
Heavy lines are mean SE, while each thin line represents a single dog
studies before and after rapid HD. Used with permission from ARIEFF
A!, GulsAno R, MASSRY SG, LAZAROWITZ VC: Central nervous
system pH in uremia and the effects of hemodialysis. J C/in invest
58:306—311, 1976
4). The increased H ion activity in brain is accompanied by an
increase of brain osmole content, which secondarily results in
an increase of brain water [58]. The cerebral edema which thus
occurs is probably the major cause of the observed clinical
manifestations of dialysis disequilibrium. The presence of post-
dialysis brain swelling has recently been documented by CAT
scan in patients with chronic renal failure [19]. The source of
the increased brain H ion is not known, but it is probably not
due to decreased cerebral blood flow, or increased cerebral
lactate production. Cerebral hypoxia is an unlikely source for
the CSF H ion, as the P°2 in CSF was normal and P°2 of CSF
is similar to that of brain. Furthermore, cerebral hypoxia should
lead to increased brain lactate, and such a phenomenon did not
occur, as brain and CSF lactate were not elevated [58]. Simi-
larly, decreased cerebral blood flow probably did not occur, as
such a circumstance should lead to a fall in P°2 of CSF, and an
increase in brain and CSF lactate. In animals treated with rapid
hemodialysis, brain and CSF lactate are normal [17, 58]. It is
theoretically possible that hemodialysis led to increased oxy-
gen-hemoglobin binding due to increased blood pH and de-
creased red cell 2,3-diphosphoglycerate [70]. The red cell levels
of 2,3-diphosphoglycerate are lower than normal in chronic
hemodialysis patients [71]. Following hemodialysis, there is a
decrease in the in vivo P50, which impairs tissue oxygen
delivery [72]. However, most chronic dialysis patients are able
to increase their cardiac output, which would serve to increase
oxygen delivery back to normal [73]. Thus, dialysis-induced
alterations of red cell 2,3-diphosphoglycerate with subsequent
hypoxia are unlikely to contribute to the observed acidosis of
the CSF. However, some dialysis patients are in fact unable to
increase their heart rate (and subsequently their cardiac output)
appropriately in response to the decrease in P50 or blood
pressure during hemodialysis. Thus, transient cerebral hypoxia
may well occur in some of these patients, particularly those
who are anemic. Although the exact biochemical sequence
leading to an increase in brain H ion is not known, rapid
hemodialysis of uremic animals may lead to an increase in brain
organic acid(s).
Brain intracellular pH and brain osmotic activity
In both mammals and amphibians in whom substantial in-
creases in extracellular osmolality are induced, brain content of
amino acids and other organic molecules increases [74—76]. The
presence in brain of strong organic acid(s) would tend to
increase osmolality by at least two mechanisms: (a) displace-
ment of intracellularly bound Na and K ions from protein
anions by H ions, as occurs in the hemoglobin molecule.
These ions, osmotically inactive when bound to intracellular
protein, may become osmotically active when displaced by an
H ion. (b) Production of increased quantities or organic acids
per ce could raise brain osmolality. Although the exact mech-
anism is unclear, rapid hemodialysis can lead to increased brain
osmolality and cerebral edema.
Prevention and management of dialysis disequilibrium
The management of dialysis disequilibrium syndrome can be
divided into preventative modalities and therapeutic maneu-
vers. In several studies, this syndrome has been treated by
addition of osmotically (or oncotically) active solute (glucose,
glycerol, albumin, urea, fructose, NaCI, mannitol) to the dialy-
sate [13, 77—79], or by substitution of sodium bicarbonate for
sodium lactate (or acetate) in the dialysate [80]. The technique
of hemofiltration is now in common use. By this technique, the
patient is subjected to ultrafiltration without dialysis, with the
net result a loss of fluid without the patient undergoing dialysis.
This procedure can then be followed by conventional dialysis
without ultrafiltration. Following the use of hemofiltration fol-
lowed by dialysis, the incidence of dialysis disequilibrium
syndrome is substantially reduced [81]. Chronic ambulatory
peritoneal dialysis (CAPD) is currently in use worldwide. By
this technique, patients undergo continuous low-volume perito-
neal dialysis for up to 24 hours/day [82]. Symptoms of dialysis
disequilibrium syndrome have not been reported in patients
undergoing CAPD [83]. In both humans and experimental
animals, the occurrence of dialysis disequilibrium syndrome
can best be prevented either by use of "slow" dialysis, that is,
low blood flow rates at frequent intervals, or by a combination
of hemofiltration followed by conventional slow hemodialysis.
Patients with certain pre-existing neurological conditions, par-
ticularly intracranial lesions (head trauma, recent stroke, brain
tumor, subdural hematoma) or conditions characterized by
cerebral edema (hyponatremia, hepatic encephalopathy, malig-
nant hypertension) are at particular risk for development of
dialysis disequilibrium and subsequent brain damage [12, 84]. If
dialysis is required in such patients, "slow" dialysis, peritoneal
dialysis, addition of mannitol, glycerol or glucose to the dialy-
sate [4, 20, 77] or substitution of bicarbonate for acetate in the
dialysate [80] should be considered.
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Future directions of research
It is now clear that dialysis disequilibrium syndrome is a
distinct clinical entity which is becoming rarer with improving
dialysis technology, particularly lower flow rates for both blood
and dialysate, smaller dialysate volumes and more frequent
dialysis. Much of the symptomatology of dialysis disequilibrium
syndrome is due to brain edema. Thus, it stands to reason that
patients with pre-existing conditions characterized by brain
edema (stroke, malignant hypertension, hyponatremia, head
trauma, hypoglycemia) will be much more susceptible to the
sequelae of dialysis disequilibrium syndrome. This will be a
particular problem in patients who have acute renal failure and
multiple medical/surgical problems, who require dialysis [121.
Brain edema may occur in such patients despite the time-tested
techniques of more frequent dialysis with lower blood flow rates
for shorter duration, or addition of mannitol, glucose or glycerol
to the dialysate. Available options could be improved upon by
identification of the "idiogenic osmoles" in brain of uremic
individuals. The technology is now available in the form of
HPLC, magnetic resonance spectroscopy, amino acid analyz-
ers. Magnetic resonance imaging can be used to determine the
effects of any treatment modalities in humans in vivo.
ALLEN I. ARIEFF
San Francisco, California, USA
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